Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
16.83
+0.23 (1.39%)
At close: Aug 21, 2026, 4:00 PM EDT
16.80
-0.03 (-0.20%)
After-hours: Aug 21, 2026, 7:30 PM EDT
Rallybio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 92.85 | 31.37 | 13.9 | 24.49 | 56.96 | 175.33 |
Short-Term Investments | - | 23.36 | 51.61 | 85.44 | 112.04 | - |
Cash & Short-Term Investments | 92.85 | 54.74 | 65.51 | 109.93 | 168.99 | 175.33 |
Cash Growth | 102.95% | -16.45% | -40.41% | -34.95% | -3.62% | 25.03% |
Prepaid Expenses | 0.77 | 0.63 | 0.64 | 0.74 | 1.55 | 1.84 |
Other Current Assets | 3.63 | 5.89 | 1.69 | 4.12 | 8.95 | 3.7 |
Total Current Assets | 97.25 | 61.25 | 67.84 | 114.79 | 179.5 | 180.87 |
Property, Plant & Equipment | - | 0.2 | 0.27 | 0.59 | 0.91 | 0.51 |
Long-Term Investments | - | - | - | 0.24 | 0.03 | 0.81 |
Other Long-Term Assets | 0.81 | 0.81 | - | - | - | - |
Total Assets | 98.06 | 62.26 | 68.11 | 115.62 | 180.44 | 182.19 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.83 | 0.13 | 0.28 | 0.98 | 1.11 | 0.6 |
Accrued Expenses | 1.47 | 3.79 | 4.96 | 8.07 | 9.45 | 5.95 |
Current Portion of Leases | - | 0.09 | 0.15 | 0.22 | 0.18 | - |
Current Unearned Revenue | - | 0.21 | 0.85 | - | - | - |
Total Current Liabilities | 3.57 | 4.22 | 6.24 | 9.26 | 10.74 | 6.55 |
Long-Term Leases | - | 0.08 | - | 0.17 | 0.37 | - |
Long-Term Unearned Revenue | - | - | 0.21 | - | - | - |
Other Long-Term Liabilities | - | - | - | - | - | 0.03 |
Total Liabilities | 3.57 | 4.31 | 6.45 | 9.44 | 11.12 | 6.58 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 361.1 | 359.93 | 354.6 | 341.41 | 330.21 | 269.63 |
Retained Earnings | -266.61 | -302 | -293.02 | -235.25 | -160.68 | -94.03 |
Comprehensive Income & Other | - | 0.02 | 0.07 | 0.02 | -0.21 | - |
Total Common Equity | 94.5 | 57.96 | 61.65 | 106.18 | 169.32 | 175.6 |
Shareholders' Equity | 94.5 | 57.96 | 61.65 | 106.18 | 169.32 | 175.6 |
Total Liabilities & Equity | 98.06 | 62.26 | 68.11 | 115.62 | 180.44 | 182.19 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | - | 0.18 | 0.15 | 0.39 | 0.56 | - |
Net Cash (Debt) | 92.85 | 54.56 | 65.36 | 109.54 | 168.44 | 175.33 |
Net Cash Growth | 103.21% | -16.52% | -40.33% | -34.97% | -3.93% | 25.03% |
Net Cash Per Share | 16.28 | 9.69 | 12.01 | 21.67 | 42.35 | 54.97 |
Filing Date Shares Outstanding | 5.31 | 5.29 | 5.2 | 4.73 | 4.76 | 4.02 |
Total Common Shares Outstanding | 5.31 | 5.28 | 5.19 | 4.73 | 4.73 | 4.02 |
Working Capital | 93.69 | 57.03 | 61.6 | 105.53 | 168.75 | 174.32 |
Book Value Per Share | 17.81 | 10.97 | 11.88 | 22.46 | 35.80 | 43.72 |
Tangible Book Value | 94.5 | 57.96 | 61.65 | 106.18 | 169.32 | 175.6 |
Tangible Book Value Per Share | 17.81 | 10.97 | 11.88 | 22.46 | 35.80 | 43.72 |
Machinery | - | 0.27 | 0.34 | 0.34 | 0.33 | 0.31 |
Construction In Progress | - | - | - | - | - | 0.01 |
Leasehold Improvements | - | 0.15 | 0.34 | 0.34 | 0.34 | 0.32 |